Why Mind Medicine Gave Investors a Powerful Buzz in May
Mind Medicine (NASDAQ: MNMD), a healthcare company that’s looking to develop treatments based on psychedelic compounds, was something of a sleeper stock in May. Several positive developments pushed the highly specialized enterprise’s share price higher, to the point where it closed the month up almost 14% in price. Rays of sunshine in May The main…